Parametric Portfolio Associates’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.9M Buy
63,616
+17,969
+39% +$526K ﹤0.01% 2443
2021
Q4
$1.06M Sell
45,647
-21,321
-32% -$567K ﹤0.01% 2755
2021
Q3
$2.09M Buy
66,968
+6,812
+11% +$211K ﹤0.01% 2422
2021
Q2
$2.12M Buy
60,156
+9,879
+20% +$321K ﹤0.01% 2403
2021
Q1
$1.77M Buy
50,277
+15,368
+44% +$567K ﹤0.01% 2866
2020
Q4
$1.31M Sell
34,909
-9,408
-21% -$342K ﹤0.01% 2914
2020
Q3
$1.48M Buy
44,317
+13,626
+44% +$397K ﹤0.01% 2685
2020
Q2
$813K Buy
30,691
+3,183
+12% +$75.1K ﹤0.01% 3029
2020
Q1
$450K Sell
27,508
-956
-3% -$21K ﹤0.01% 3217
2019
Q4
$724K Buy
28,464
+8,771
+45% +$175K ﹤0.01% 3217
2019
Q3
$394K Sell
19,693
-995
-5% -$25.8K ﹤0.01% 3425
2019
Q2
$667K Sell
20,688
-2,505
-11% -$83.8K ﹤0.01% 3246
2019
Q1
$747K Sell
23,193
-1,023
-4% -$27.5K ﹤0.01% 3168
2018
Q4
$594K Sell
24,216
-6,223
-20% -$164K ﹤0.01% 3231
2018
Q3
$1M Buy
30,439
+9,599
+46% +$314K ﹤0.01% 3096
2018
Q2
$740K Buy
20,840
+4,485
+27% +$145K ﹤0.01% 3189
2018
Q1
$533K Buy
+16,355
New +$551K ﹤0.01% 3316

Other funds holding ALBO

Parametric Portfolio Associates's ALBO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Albireo Pharma Inc (ALBO) stake by 39% in Q1 2022, buying an estimated $526K and bringing the position to 63,616 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2443.

Parametric Portfolio Associates first reported a position in ALBO in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.12M in Q2 2021. 110 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.

  • Parametric Portfolio Associates held 63,616 shares of Albireo Pharma Inc worth $1.9M as of Q1 2022.
  • Parametric Portfolio Associates bought 17,969 Albireo Pharma Inc shares in Q1 2022, an estimated $526K.
  • Albireo Pharma Inc made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2443 holding.
  • Parametric Portfolio Associates first reported a position in Albireo Pharma Inc in Q1 2018 and has held it in 17 quarters since.
  • Parametric Portfolio Associates's Albireo Pharma Inc position peaked at $2.12M in Q2 2021.
  • 110 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.